Cashu
Legal Action Against REGENXBIO's Dr. Pakola Highlights Gene Therapy Safety Concerns
about 11 hours ago
Stocks
Health Care
rgnx
Regenxbio
NASDAQ: RGNX
-0.10 (-1.16%)
8.53
USD
At close at Apr 03, 19:40 UTC
Latest Regenxbio News
prnewswire.com
REGENXBIO, Inc. Class Action Reminder - Robbins LLP Encourages RGNX Stockholders to Contact the Firm for Information About Their Rights
24 minutes ago
prnewswire.com
STEPHEN PAKOLA OVERSAW RGX-111 SAFETY CLAIMS THAT COST RGNX INVESTORS MILLIONS: LEVI & KORSINSKY, LLP
2 days ago
prnewswire.com
RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit
4 days ago
prnewswire.com
REGENXBIO Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RGNX
4 days ago
prnewswire.com
RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm
4 days ago
prnewswire.com
SUEWALLST, LLP: INSTITUTIONAL RGNX HOLDERS FACE PORTFOLIO LOSSES FROM GENE THERAPY FRAUD
8 days ago
benzinga.com
FDA Clears Denali Therapeutics Drug As First Brain-Penetrating Biologic For Rare Disease
8 days ago
prnewswire.com
STEPHEN PAKOLA OVERSAW RGX-111 SAFETY CLAIMS THAT COST RGNX INVESTORS MILLIONS: LEVI & KORSINSKY, LLP
9 days ago
prnewswire.com
RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit
10 days ago
prnewswire.com
RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit
15 days ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.